Invention Grant
- Patent Title: Indolizine derivatives as phoshoinositide 3-kinases inhibitors
- Patent Title (中): 吲哚啉衍生物作为磷酸肌醇3-激酶抑制剂
-
Application No.: US14741965Application Date: 2015-06-17
-
Publication No.: US09527869B2Publication Date: 2016-12-27
- Inventor: Matteo Biagetti , Alessandro Accetta , Anna Maria Capelli , Matilde Guala , Michele Retini
- Applicant: CHIESI FARMACEUTICI S.P.A.
- Applicant Address: IT Parma
- Assignee: CHIESI FARMACEUTICI S.p.A.
- Current Assignee: CHIESI FARMACEUTICI S.p.A.
- Current Assignee Address: IT Parma
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: EP14172764 20140617
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D471/04 ; C07D473/02 ; C07D519/00 ; A61K31/519 ; A61K31/5377 ; A61K31/53 ; A61K31/52 ; A61K31/506 ; A61K31/497 ; A61P19/02 ; A61P11/00 ; A61P11/02
Abstract:
Compounds of formula (I), defined herein, inhibit phosphoinositide 3-kinases (PI3K) and are useful for the treatment of disorders associated with PI3K enzymes.
Public/Granted literature
- US20150361100A1 INDOLIZINE DERIVATIVES AS PHOSHOINOSITIDE 3-KINASES INHIBITORS Public/Granted day:2015-12-17
Information query
